{"schema_version":"secwatch.filing_event.v1","accession":"0001551306-23-000005","form_type":"8-K","ticker":"PGNY","cik":"0001551306","company_name":"Progyny, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.536293+00:00","generated_at":"2026-06-20T17:48:37.124226+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Progyny reaffirms FY2022 high-end guidance; expects record Q4 operating cash flow ~$50M","bullets":["Q4 and FY2022 revenue, net income, Adj. EBITDA expected at or near high-end of guidance issued Nov 28, 2022.","Record Q4 operating cash flow of ~$50M; full-year ~$79M, reflecting high capital efficiency.","More than 370 clients and 5.4 million covered lives for 2023; substantially all new clients already launched.","Record new client wins in 2022; over 25% of existing clients expanded relationships despite macro environment.","Early 2023 selling season activity very encouraging; family building benefits remain top employer priority."],"urls":{"canonical":"https://secwatch.observer/filing/0001551306-23-000005","json":"https://secwatch.observer/filing/0001551306-23-000005.json","markdown":"https://secwatch.observer/filing/0001551306-23-000005.md","text":"https://secwatch.observer/filing/0001551306-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551306/000155130623000005/0001551306-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551306/000155130623000005/pgny-20230109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:48:37.124226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13455edc75f2758009a92d8287862e157fa24ee0","claim":"Progyny, Inc. updated its quarter and year ended December 31, 2022 guidance (reaffirmed).","evidence_excerpt":"Progyny, Inc. (the “Company”) issued a press release to reaffirm the Company’s previously issued financial guidance for the three months and year ending December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155130623000005/0001551306-23-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter and year ended December 31, 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}